Rotem Industries
Website to be confirmed.
About Rotem Industries
A Isotope Supply player with a presence on the SNMMI floor; commercial activity worth a closer look.
Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.
What we're seeing
- PR Newswire · 2026-06-19Rotem Industries announces Phase II readout for lead theranostic candidateDetails remain limited but analysts read the move as a positioning play ahead of pivotal data.
- Nuclear Medicine Today · 2026-05-24Rotem Industries expands cyclotron capacity to meet Lu-177 demandCoverage notes the company's growing footprint in the radioligand therapy space.
- STAT News · 2026-12-05Rotem Industries signs supply agreement to support late-stage trialsThe work builds on more than a decade of radiochemistry collaboration.
- Imaging Wire · 2026-03-26Rotem Industries appoints new Chief Medical Officer ahead of pivotal trialThe work builds on more than a decade of radiochemistry collaboration.
Mocked while we wire the Exa integration. Headlines are illustrative.
What we expect to see at the booth
Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.
A short Bracken POV will go here, drawing on our experience across this part of the radiopharma value chain. Specific commentary to be filled in by the team.
Editorial shown for exhibitors in Bracken's wheelhouse: radiopharma developers, isotope supply, CDMO/CMO, cyclotron, and imaging equipment.
Companies you may also want to visit.
ABX advanced biochemical compounds
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on ABX advanced biochemical compounds.
View profile →BWXT Medical Ltd.
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on BWXT Medical Ltd..
View profile →Eckert & Ziegler Isotope
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Eckert & Ziegler Isotope.
View profile →